Association for Accessible Medicines filed 2 comments on this docket between Apr 3, 2023 and Aug 1, 2025. 0 other organizations filed here. The comment window closed 292d ago.
FDA, Please find attached comments from the Association for Accessible Medicines (AAM) regarding Docket No. FDA–2023–D–0093 "M13B Bioequivalence for Immediate-Release Solid Oral Dosage Forms: Additional Strengths Biowaiver; International Council for Harmonisation; Draft Guidance for Industry." Thanks, Scott Kuzner, Ph.D., Senior Director, Sciences and Regulatory Affairs, AAM
FDA, Please find attached comments from The Association for Accessible Medicines (AAM) regarding Docket No. FDA-2023-D-0093, "M13A Bioequivalence for Immediate-Release Solid Oral Dosage Forms; International Council for Harmonisation; Draft Guidance for Industry." Thanks, Scott Kuzner, Ph.D., Senior Director, Sciences and Regulatory Affairs Association for Accessible Medicines (AAM)
Open
View on regulations.gov →